In the December 2014 issue of The Antitrust Source, John Woodbury comments on a working paper co-authored by two CRA economists, José Azar and Isabel Tecu (as well as Martin Schmalz) that examines the effect institutional investors may have on softening competition downstream. To read the article, click the link below.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...